Article
Are WHO approved nucleic acid amplification tests causing large-scale "false identification" of rifampicin-resistant tuberculosis?: Programmatic experience from south india.
International journal of mycobacteriology - 1 Jan 2000
Sanker Praveen, Ambika Anusree P, Santhosh Vishnu T, Kottuthodi Ramya Puthukkudi, Balakrishnan Ravikrishnan, Mrithunjayan Sunil Kumar, Moosan Hisham
Abstract excerpt
INTRODUCTION: The nucleic acid amplification tests (NAATs): Line probe assay and GeneXpert (Xpert) have evolved as the primary tool for identification of rifampicin (RIF)-resistant (RR) tuberculosis (TB) worldwide, primarily because of the ease and speed. We rechecked RR isolates identified by NAATs from presumptive RR TB cases belonging to South India by the Revised National TB Control Program, India using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.